167 filings
Page 2 of 9
6-K
01x4h9rf4x0 s9sxnbi
6 Dec 23
Immunoprecise Antibodies LTD. 6-K
7:57am
6-K
xj2zwlh1lldi1p
6 Dec 23
Immunoprecise Antibodies LTD. 6-K
6:01am
424B5
a0o1sy22
5 Dec 23
Prospectus supplement for primary offering
4:02pm
6-K
h5c07
27 Nov 23
Immunoprecise Antibodies LTD. 6-K
8:31am
6-K
pinspvn0nouqqz510an
16 Nov 23
Report of Voting Results
5:13pm
6-K
t4sgj 4aactud8ase
13 Nov 23
Immunoprecise Antibodies LTD. 6-K
8:50am
6-K
p1z07uatoc3 vb
25 Oct 23
BioStrand Unveils Groundbreaking Retrieval Augmented Generation (RAG)-Based LLM Platform Integrated with Patented HYFT Technology
8:01am
6-K
4no6tdx5urf4hyosro
23 Oct 23
Immunoprecise Antibodies LTD. 6-K
8:01am
6-K
f49gx9p y2c45bbrtrij
20 Oct 23
Current report (foreign)
2:56pm
6-K
26wwgq
26 Sep 23
Material Change Report
11:56am
6-K
5gwfrgrplx3fer 5c
25 Sep 23
Current report (foreign)
4:46pm
6-K
3kd2f60ve7mu t2et
19 Sep 23
Immunoprecise Antibodies LTD. 6-K
8:02am
6-K
k3zl70 f0k3jkk
18 Sep 23
Statement of Executive Compensation
2:47pm
6-K
yblp3rdq dah6q
14 Sep 23
Current report (foreign)
8:02am
6-K
szar dx1o
14 Sep 23
Immunoprecise Antibodies LTD. 6-K
8:01am
6-K
mppwgv yv
12 Sep 23
Material Change Report
6:20pm
6-K
zr5fhddh3g1ie zbdk
8 Sep 23
The Company to host an earnings conference call via webcast
8:30am
6-K
qek9j6fgi ou
5 Sep 23
IPA appoints Barry A. Springer, Dirk Witters and Chris Buyse to the Board of Directors
8:14am
6-K
y12voywb
15 Aug 23
Current report (foreign)
5:50pm
424B5
qguue6 mwpbvsbe
15 Aug 23
Prospectus supplement for primary offering
5:47pm